Cystic Fibrosis & AST Webinars

On Demand Webinars | P.A.C.E Credits Available

Trends in Bacterial Resistance and New Antibiotic Treatments for Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis

Chronic pulmonary infections in cystic fibrosis patients is an ongoing challenge. The emergence of multi-drug-resistant mucoid organisms, such as Pseudomonas aeruginosa, has further complicated these infections. At the end of the webinar, attendees should be able to:

  • List problem bacterial pathogens in CF patients and other current resistance trends in this population
  • Describe challenges with microbiological identification and susceptibility testing of CF pathogens
  • Identify new antibiotics that may play a role in the treatment of acute pulmonary exacerbations in patients with CF



ETEST® Technology Overview: Supporting Antimicrobial Stewardship Initiatives

Due to exposure to antibiotics from an early age, individuals with CF often have drug-resistant organisms colonizing their respiratory tract. With CF patients living well into adulthood, preservation of antimicrobials is essential now more than ever. At the end of the webinar, attendees should be able to:

  • List the steps and requirements for testing & determining MICs
  • Discuss how to support stewardship initiatives



Pioneering Diagnostics